Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Arianna Precisi"'
Autor:
Paolo De Simone, Arianna Precisi, Quirino Lai, Juri Ducci, Daniela Campani, Piero Marchetti, Stefano Gitto
Publikováno v:
Cancers, Vol 16, Iss 7, p 1243 (2024)
To obtain long-term data on the use of everolimus in patients who underwent liver transplantation for hepatocellular carcinoma, we conducted a retrospective, single-center analysis of adult recipients transplanted between 2013 and 2021. Patients on e
Externí odkaz:
https://doaj.org/article/53b057bf76db4883a2a7d3a42bd2862b
Autor:
Paolo De Simone, Paola Carrai, Giulia Leonardi, Alessandro Silvestri, Davide Ghinolfi, Arianna Precisi, Daniela Campani, Franco Filipponi
Publikováno v:
European Medical Journal Hepatology, Vol 2, Iss 1, Pp 77-85 (2014)
Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients. No information is currently available on use of HBsAg levels to guide HBV immune globulin (HBIG) administr
Externí odkaz:
https://doaj.org/article/75323f2ccd0c41eca028546dab78df31
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valentina Spallanzani, Irene Bianco, A. Mazzoni, Arianna Precisi, L Bindi, Gianni Biancofiore, Paolo DeSimone
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 56(2)
Immunosuppressive medication dosing errors are not unfrequent and may present a number of challenges to transplant clinicians. Tacrolimus (TAC) is a widely used immunosuppressant with a narrow therapeutic index and potential severe side effects, incl
Autor:
Paolo De Simone, Paola Carrai, Arianna Precisi, Stefania Petruccelli, Lidiana Baldoni, Emanuele Balzano, Juri Ducci, Francesco Caneschi, Laura Coletti, Daniela Campani, Franco Filipponi
We present the 12-month results of a prospective trial of conversion from calcineurin inhibitors (CNI) to everolimus (EVL) in maintenance liver transplant (LT) recipients. Forty (M:F = 28:12; 54.9 +/- 11 years) patients were enrolled at a mean interv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc5a4be8aef699ccd461b69c7e8bd4f
http://hdl.handle.net/11568/196533
http://hdl.handle.net/11568/196533